The white matter injury treatment market is projected to grow from USD 1.2 billion in 2025 to USD 2.9 billion by 2035, at a CAGR of 9.1%. Drug Based Treatment will dominate with a 40.0% market share, while hospitals will lead the end users segment with a 50.0% share.